Elizabeth Bailey

Managing Partner at Foreground Capital

Speaker

Elizabeth Bailey has over 20 years of experience in venture capital and supporting early-stage healthcare companies. She is currently a Co-founder and Managing Partner at Foreground Capital, a venture capital firm investing in early-stage women’s health start-ups. Elizabeth co-founded and led Foreground’s precursor funds at RH Capital, where she and her team built one of the largest dedicated venture capital portfolios in women’s health. At Foreground Capital, she continues to manage RH Capital funds and serves as a board director for Raydiant Oximetry and Testmate Health, and as a board observer for Bloomlife, Cayaba, Mae and Twentyeight Health.

Elizabeth was previously a Partner at Commons Capital, one of the first impact investment funds, where she managed the healthcare portfolio, including Claros Diagnostics (acquired by OPKO), CodeRyte (acquired by 3M), HistoRx (acquired by Genoptix), Medical Metrx Solutions (acquired by AIG) and TelaDoc (IPO: TDOC).

She holds a Masters in Public Policy from Harvard Kennedy School and a BA from Brown University. Throughout her career, Elizabeth has been a strong advocate of the power of business to drive social change. She has been named twice as a Trailblazing Leader in Women’s Health and received the inaugural FemForce Vanguard Award for her leadership in women’s health.